Table 2.
Chemical characterization of lipopeptides from Bacillus and Paenibacillus species by UPLC-QTOF-MS: a = LIS04; b = CT02; c = LIS05; d = IM14.
| Peak | RT (min) | Compounds | CFS* | Molecular formula | Ion m/z | Error (ppm) | Fragment ions m/z | References |
|---|---|---|---|---|---|---|---|---|
| 1 | 10.29 | Lipopeptide ND*-1 | a | C47H63N8O7 | 851.4822 [M + H]+ | 0.2 | 437; 409 | – |
| 2 | 12.44 | Iturin A2 | c,d | C48H74N12O14 | 1,043.5519 [M + H]+ | −0.7 | 299; 801; 915 | Ye et al., 2012 |
| 3 | 12.95 | Lipopeptide ND-2 | a | C47H75N10O11 | 955.5617 [M + 2H]+ | −0.9 | 478; 353 | – |
| 4 | 13.25 | Iturin A3–A5 | d | C49H76N12O14 | 1,057.5995 | 1.2 | – | Souza et al., 2018 |
| 5 | 13.59 | C14 Fengycin A | b, c, d | C70H107N12O20 | 718.3788 [M + 2H]+ | 1.7 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 6 | 13.79 | C16 Fengycin A | b | C72H114N12O20 | 741.3965 [M + 2H]+ | 3.9 | 966; 1,080 | Ma et al., 2016 |
| 7 | 13.94 | C16Fengycin A | b | C72H114N12O20 | 741.3937 [M + 2H]+ | 0.1 | 966; 1,080 | Ma et al., 2016 |
| 8 | 14.06 | C15 Fengycin A | b, d | C71H108N12O20 | 725.4003 [M + 2H]+ | 2.3 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 9 | 14.33 | C15Fengycin A | d | C71H108N12O20 | 725.3876[M + 2H]+ | 0.7 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 10 | 14.44 | C15Fengycin A | b, c, d | C71H108N12O20 | 725.3986 [M + 2H]+ | −3.7 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 11 | 14.60 | Lipopeptide ND-3 | a | C25H44N5O4 | 478.3410[M + H]+ | 3.6 | 376, 162 | – |
| 12 | 14.79 | C16Fengycin A | b, c, d | C72H110N12O20 | 732.3915 [M + 2H]+ | −2.3 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 13 | 15.20 | C17 Fengycin A | b, c, d | C72H110N12O20 | 739.3990 [M + 2H]+ | 3.9 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 14 | 15.24 | C16 Fengycin B | b, c, d | C74H114N12O20 | 746.4111 [M + 2H]+ | 2.9 | 966; 1,080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 15 | 15.79 | C17 Fengycin B | b, c | C75H116N12O20 | 753.4147 [M + 2H]+ | 3.6 | 994; 1,180 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 16 | 16.02 | C16 Fengycin B | b, c | C74H114N12O20 | 746.4069 [M + 2H]+ | −2.0 | 994 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 17 | 16.14 | C17 Fengycin A | b | C72H110N12O20 | 739.4049 [M + 2H]+ | −2.3 | 966; 1080 | Souza et al., 2018; Villegas-Escobar et al., 2018 |
| 18 | 16.42 | C18Fengycin B | b, c, d | C76H119N12O20 | 760.4244[M + 2H]+ | 1.0 | 994; 1022; 1180 | Ma et al., 2016 |
| 19 | 17.60 | Lipopeptide ND-4 | a | C56H98N16O13 | 602.4215[M + 2H]+ | 2.3 | 562; 662 | – |
| 20 | 18.59 | Lipopeptide ND-5 | a | C17H21N2O7 | 365.1349[M + H]+ | 1.7 | 163, 105 | – |
| 21 | 21.49 | C14 Surfactin | b, c | C45H97N7O19 | 1,040.6917 | −0.1 | 685; 909; 1022 | Ma et al., 2016 |
| 22 | 22.35 | C12 Surfactin | b, c | C43H91N7O18 | 994.6500 | 0.1 | 685; 873; 976 | Tang et al., 2010; Ma et al., 2016 |
| 23 | 22.61 | Surfactin | b, c | C56H91N7O12 | 1,054.6807 [M + H]+ | 0.3 | 441; 554 | Ma et al., 2016 |
| 24 | 22.98 | Surfactin | b, c | C51H89N7O13 | 1,008.6611 | 1.4 | 455; 667; 895 | Souza et al., 2018 |
| 25 | 23.58 | Surfactin | b, c, d | C51H89N7O13 | 1,008.6600 | 0.3 | 455; 667; 895 | Souza et al., 2018 |
| 26 | 23.79 | Surfactin | b, c, d | C52H91N7O13 | 1,022.6726 | −2.6 | 582; 796; 909 | Souza et al., 2018 |
| 27 | 23.97 | Surfactin | b, c, d | C52H91N7O13 | 1,022.6714 | −3.8 | 582; 796; 909 | Souza et al., 2018 |
| 28 | 24.28 | Surfactin | c | C51H89N7O13 | 1,008.6581 [M + H]+ | −1.6 | 455; 667; 895 | Souza et al., 2018 |
| 29 | 24.51 | Surfactin | b, c, d | C53H93N7O13 | 1,036.6929 | 1.8 | 441; 685; 923 | Souza et al., 2018 |
| 30 | 24.88 | Surfactin | c | C53H93N7O13 | 1,036.6910 [M + H]+ | 0.8 | 441; 685; 923 | Souza et al., 2018 |
ND. not determined.
*Cell-free supernatant.